Henan Lingrui Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥13.68 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	18.14
Forward PE	16.64
Price to Sales TTM	CN¥3.79
Price to Book MRQ	CN¥4.12
Enterprise to Revenue	3.35
Enterprise to EBITDA	14.59

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	20.73%
Operating Margin	23.46%
Return on Assets TTM	9.12%
Return on Equity TTM	23.83%

Income Statement

Revenue TTM	CN¥3,612,540,416
Revenue per Share TTM	CN¥6.42
Quarterly Revenue Growth	12.30%
Gross Profit TTM	CN¥2,748,849,920
EBITDA	CN¥867,700,219
Net Income to Common TTM	CN¥748,989,632
Diluted EPS TTM	CN¥1.33
Quarterly Earnings Growth YoY	13.90%

Balance Sheet

Total Cash MRQ	CN¥862,569,984
Total Cash per Share MRQ	CN¥1.52
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	2.66
Current Ratio MRQ	1.01
Book Value per Share MRQ	CN¥5.85

Cash Flow

Operating Cash Flow TTM	CN¥948,573,824
Levered Free Cash Flow TTM	CN¥486,061,952

600285 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	567,115,486
Float Shares	432,474,570
Avg 10 Volume	6,891,444
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	22.88%
% Held by Institutions	21.63%

Stock Price Summary

Beta	0.27
Fifty Two Week Low	CN¥18.49
Fifty Two Week High	CN¥27.26
Fifty Two Week Change	-3.15%
Day 50 MA	CN¥23.33
Day 200 MA	CN¥22.33

Dividends and Splits

Forward Annual Dividend Rate	CN¥3.60
Forward Annual Dividend Yield	15.31%
Trailing Annual Dividend Rate	CN¥0.90
Trailing Annual Dividend Yield	3.83%
Payout Ratio	60.29%
Dividend Date
Ex Dividend Date	2025-06-20
Last Split Factor
Last Split Date	2014-07-02